Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion

Kit Ming Lee, Clive S. McKimmie, Derek S. Gilchrist, Kenneth J. Pallas, Robert J. Nibbs, Paul Garside, Victoria McDonald, Christopher Jenkins, Richard Ransohoff, LiPing Liu, Simon Milling, Vuk Cerovic, Gerard J. Graham

Blood (2011) 118 (23): 6220–6229.

https://doi.org/10.1182/blood-2011-03-344044

Published: 2011

Includes: Supplemental data

Journal Articles

Notch-Mediated Suppression of PKCθ Reduces Reactive Oxygen Species and Promotes Leukemic Stem Cell Activity In T-Cell Acute Lymphoblastic Leukemia (T-ALL)

Vincenzo Giambra, PhD, Oksana Nemirovsky, Sonya Lam, Christopher Jenkins, Carol Wai, Hind Medyouf, PhD, R. Keith Humphries, PhD, Connie J. Eaves, PhD, Andrew P Weng, MD, PhD

Blood (2010) 116 (21): 12.

https://doi.org/10.1182/blood.V116.21.12.12

Published: 2010

Journal Articles

Cellular Aminopeptidase Inhibition as a Target for the Therapy of AML by the Novel Agent CHR 2797.

Christopher Jenkins, MB, BCh, Ken Mills, PHD, Chris Pepper, PHD, Burnett Alan, MB BCh

Blood (2007) 110 (11): 1608.

https://doi.org/10.1182/blood.V110.11.1608.1608

Published: 2007

Journal Articles

NF Kappa B as a Therapeutic Target in AML.

Christopher Jenkins, MBBCh, Chris Pepper, Ken Mills, Alan Burnett

Blood (2006) 108 (11): 2587.

https://doi.org/10.1182/blood.V108.11.2587.2587

Published: 2006

Journal Articles

Inhibition of Cellular Aminopeptidases as Novel Therapy for AML.

Christopher Jenkins, MBBCh, Chris Pepper, Ken Mills, Alan Burnett

Blood (2006) 108 (11): 2588.

https://doi.org/10.1182/blood.V108.11.2588.2588

Published: 2006

Journal Articles

NF Kappa B as a Therapeutic Target in AML.

Christopher Jenkins, MB, Christopher J. Pepper, PhD, Ken I. Mills, PhD, Alan K. Burnett, MD

Blood (2005) 106 (11): 2770.

https://doi.org/10.1182/blood.V106.11.2770.2770

Published: 2005

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion

Notch-Mediated Suppression of PKCθ Reduces Reactive Oxygen Species and Promotes Leukemic Stem Cell Activity In T-Cell Acute Lymphoblastic Leukemia (T-ALL)

Cellular Aminopeptidase Inhibition as a Target for the Therapy of AML by the Novel Agent CHR 2797.

NF Kappa B as a Therapeutic Target in AML.

Inhibition of Cellular Aminopeptidases as Novel Therapy for AML.

NF Kappa B as a Therapeutic Target in AML.

Email alerts

ASH Publications

American Society of Hematology

Update search

D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion

Notch-Mediated Suppression of PKCθ Reduces Reactive Oxygen Species and Promotes Leukemic Stem Cell Activity In T-Cell Acute Lymphoblastic Leukemia (T-ALL)

Cellular Aminopeptidase Inhibition as a Target for the Therapy of AML by the Novel Agent CHR 2797.

NF Kappa B as a Therapeutic Target in AML.

Inhibition of Cellular Aminopeptidases as Novel Therapy for AML.

NF Kappa B as a Therapeutic Target in AML.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only